New smart drug targets, reduces site-specific inflammation

22 julio 2015

The uniqueness of a new novel anti-inflammatory molecule can be found in a singular property. When injected, it is as a non-active drug. However, a localized site with excessive inflammation will activate it. Most other anti-inflammatory agents effectively inhibit inflammatory processes, though in a non-specific manner and in areas that include sites of necessary normal inflammatory homeostasis.img src=»» height=»1″ width=»1″ alt=»»/